ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3054% below fair value
$71.44+0.38 (+0.53%)
Close on Nov 13, 2026Market cap $1.64BP/E 13.5Yield –
ANI Pharmaceuticals statistics
106 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 26, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 11.60
- 2.22
- P/OCF Ratio
- 7.16
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 1.46
- 2.57
- EV / EBIT
- 9.12
- 19.31
- EV / FCF
- 7.39
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 7.94%
- 10.8%
- Float
- 20M
- 49M
- Shares Held by Insiders
- 12.3%
- 11.7%
- Shares Held by Institutions
- 100.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 3.21%
- -0.80%
- Short % of Float
- 17.8%
- 9.01%
- Short % of Shares Outstanding
- 15.6%
- 6.30%
- Days to Cover
- 11.88
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $87.89
- –
- 52-Week Low
- $67.14
- –
- 20-Day Moving Average
- $71.44
- –
- 50-Day Moving Average
- $72.31
- –
- 200-Day Moving Average
- $77.01
- –
- Average True Range (14)
- $2.37
- –
- Price Change (1 Week)
- 5.98%
- -1.15%
- Price Change (1 Month)
- -1.16%
- -4.87%
- Price Change (3 Months)
- -6.00%
- -21.0%
- Price Change (6 Months)
- -8.42%
- -20.6%
- Price Change (YTD)
- -9.50%
- -23.6%
- Price Change (1 Year)
- -18.1%
- -22.4%
- Price Change (3 Years)
- 34.2%
- -29.5%
- Price Change (5 Years)
- 56.8%
- -77.9%
- Price Change (10 Years)
- 19.2%
- -65.4%
- Average Volume (10 Days)
- 649,367
- –
- Average Volume (20 Days)
- 476,502
- –
- Average Volume (90 Days)
- 394,929
- –
- Relative Volume
- 0.97
- 0.70
- Relative Strength Index (14)
- 49.7
- 43.4
- Volatility (1 Year)
- 31.9%
- 80.1%
- Beta (5 Years)
- 0.61
- 1.07
MarginsIndustry
- Pretax Margin
- 15.2%
- -11.6%
- EBITDA Margin
- 23.9%
- -27.7%
- FCF Margin
- 19.7%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 20.4%
- -49.9%
- Return on Assets (ROA)
- 7.85%
- -40.6%
- Return on Invested Capital (ROIC)
- 23.0%
- -32.9%
- Return on Capital Employed (ROCE)
- 13.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.75
- 3.30
- Quick Ratio
- 2.21
- 2.39
- Debt / Equity
- 0.47
- 0.49
- Debt / EBITDA
- 1.19
- 3.15
- Debt / FCF
- 1.45
- 4.65
- Net Debt / EBITDA
- -0.49
- 1.97
- Interest Coverage
- 5.44
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 25.9%
- 6.82%
- Net Income Growth (YoY)
- 188.0%
- -14.4%
- EPS Growth (YoY)
- 225.2%
- -12.3%
- FCF Growth (YoY)
- 31.8%
- 6.85%
- Revenue Growth (3Y CAGR)
- 40.8%
- 2.25%
- Revenue Growth (5Y CAGR)
- 33.5%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.70
- 0.40
- Inventory Turnover
- 2.87
- 2.73
- Revenue Per Employee
- $1.07M
- $429.29K
- Profits Per Employee
- $120.46K
- -$689.41K
- Employee Count
- 970
- 74
- WACC
- 8.06%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $157.84M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $123.08M
- $17.76M
- Net Cash Per Share
- $5.36
- $0.80
- Equity (Book Value)
- $637.11M
- $53.89M
- Book Value Per Share
- $27.74
- $1.50
- Tangible Book Value
- $141.52M
- $27.13M
- Working Capital
- $574.10M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$23.87M
- -$1.00M
- FCF Per Share
- $8.94
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 7.12%
- -21.8%
- FCF Yield
- 12.5%
- -9.44%
- Buyback Yield
- 1.17%
- -0.76%
- Shareholder Yield
- 1.17%
- 0.00%
- Payout Ratio
- 0.00%
- 55.4%
- FCF Payout Ratio
- 0.00%
- 43.7%
Taxes and interestIndustry
- Interest Expense
- $30.59M
- $2.90M
- Income Tax
- $41.00M
- $73.00K
- Effective Tax Rate
- 26.0%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $57.51
- $19.34
- Graham Upside
- -19.5%
- -46.6%
- Altman Z-Score
- 2.57
- 0.23
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -2.64
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ANIP | S&P 500 | Difference | ANIP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.8% | -3.0% | +3.9 pts | ||
| 3 months | -4.5% | -2.8% | −1.7 pts | ||
| Year to date | -9.5% | +11.5% | −21.0 pts | ||
| 1 year | -15.5% | +13.5% | −29.0 pts | ||
| 3 years | +38.3% | +77.7% | −39.4 pts | +11.4% | +21.1% |
| 5 years | +56.8% | +72.6% | −15.8 pts | +9.4% | +11.5% |
| 10 years | +24.1% | +308.2% | −284.1 pts | +2.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M ANIP shares were sold short on Oct 30, 2026, up 3.2% from the previous report, or 17.78% of the shares available to trade. At recent volumes it would take 11.9 days to buy them back. Over the last 20 sessions, 54.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,583,674 | +3.2% | 301,720 | 11.9 |
| Oct 15, 2026 | 3,472,078 | -0.6% | 343,760 | 10.1 |
| Sep 30, 2026 | 3,491,281 | +40.2% | 487,356 | 7.2 |
| Sep 15, 2026 | 2,490,166 | -26.0% | 334,880 | 7.4 |
| Aug 31, 2026 | 3,364,919 | -1.6% | 364,912 | 9.2 |
| Aug 14, 2026 | 3,420,781 | +46.6% | 464,263 | 7.4 |
| Jul 31, 2026 | 2,334,112 | -30.8% | 252,428 | 9.3 |
| Jul 15, 2026 | 3,371,249 | -2.1% | 307,319 | 11.0 |
| Jun 30, 2026 | 3,442,249 | +7.5% | 365,430 | 9.4 |
| Jun 15, 2026 | 3,201,694 | -3.7% | 293,393 | 10.9 |
| May 29, 2026 | 3,324,397 | -8.2% | 336,455 | 9.9 |
| May 15, 2026 | 3,621,862 | +1.7% | 469,503 | 7.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?